You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新股暗盤丨康諾亞-B(2162.HK)暗盤大幅收漲31.52% 此前公開發售獲認購429.97倍
格隆匯 07-07 19:20
格隆匯7月7日丨據富途,康諾亞-B(2162.HK)暗盤段高開高走,大幅收漲31.52%,報70.10港元且為暗盤交易最高價,每手賺8400港元,市值達189.97億港元。康諾亞生物是一家生物科技公司,專注於自主研發自體免疫及腫瘤治療領域的創新生物療法。公司發行約5826.50萬股股份,每股定價53.30港元,每手500股,公開發售階段康諾亞-B獲429.97倍認購。基石投資者已認購合共2767.15萬股發售股份,合計佔緊隨全球發售完成後公司已發行股本約10.21%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account